SJS Investment Consulting’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.18K Buy
764
+646
+547% +$4.99K ﹤0.01% 1165
2026
Q1
$752 Buy
118
+89
+307% +$619 ﹤0.01% 1589
2025
Q4
$205 Sell
29
-1
-3% -$6 ﹤0.01% 1802
2025
Q3
$165 Buy
30
+29
+2,900% +$142 ﹤0.01% 1507
2025
Q2
$6 Sell
1
-42
-98% -$252 ﹤0.01% 1544
2025
Q1
$287 Sell
43
-14
-25% -$106 ﹤0.01% 1389
2024
Q4
$421 Buy
57
+49
+613% +$352 ﹤0.01% 1303
2024
Q3
$56 Hold
8
﹤0.01% 1609
2024
Q2
$40 Hold
8
﹤0.01% 1629
2024
Q1
$50 Hold
8
﹤0.01% 1607
2023
Q4
$63 Sell
8
-21
-72% -$135 ﹤0.01% 1581
2023
Q3
$200 Buy
29
+28
+2,800% +$227 ﹤0.01% 1456
2023
Q2
$10 Hold
1
﹤0.01% 1585
2023
Q1
$8 Sell
1
-1
-50% -$6 ﹤0.01% 1574
2022
Q4
$10 Buy
+2
New +$12 ﹤0.01% 1586

Other funds holding LFST

SJS Investment Consulting's LFST Position: Q2 2026 in Review

SJS Investment Consulting increased its Lifestance Health (LFST) stake by 547% in Q2 2026, buying an estimated $4.99K and bringing the position to 764 shares worth $8.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

SJS Investment Consulting first reported a position in LFST in Q4 2022 and has held it in 15 quarters since. 120 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • SJS Investment Consulting held 764 shares of Lifestance Health worth $8.18K as of Q2 2026.
  • SJS Investment Consulting bought 646 Lifestance Health shares in Q2 2026, an estimated $4.99K.
  • Lifestance Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1165 holding.
  • SJS Investment Consulting first reported a position in Lifestance Health in Q4 2022 and has held it in 15 quarters since.
  • 120 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.